Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
Beeline Medicines has raised $300.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Beeline Medicines's investors include Bain Capital.
Beeline Medicines is headquartered in Boston, United States.
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
Beeline Medicines is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beeline Medicines — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/beeline-medicines. Accessed August 14, 2026.
VCBacked. (2026). Beeline Medicines — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/beeline-medicines
{{cite web |title=Beeline Medicines — Funding & Investors |url=https://www.vcbacked.co/company/beeline-medicines |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated